Donald Notman, Chief Operating Officer at OCULAR THERAPEUTIX, INC (OCUL), sold 11,446 shares at $9.04 ($103K) on 2026-02-12, disclosed to the SEC on 2026-02-17.
Seasonal sale ($103k) by Chief Operating Officer — this insider has traded OCUL in February in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| OCUL | SELL | 2025-09-04 | $13K | — | Filing → |
| OCUL | SELL | 2025-02-04 | $223K | — | Filing → |
| OCUL | SELL | 2024-02-06 | $30K | — | Filing → |